1. Home
  2. LGND vs ZGN Comparison

LGND vs ZGN Comparison

Compare LGND & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • ZGN
  • Stock Information
  • Founded
  • LGND 1987
  • ZGN 1910
  • Country
  • LGND United States
  • ZGN Italy
  • Employees
  • LGND N/A
  • ZGN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • ZGN Apparel
  • Sector
  • LGND Health Care
  • ZGN Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • ZGN Nasdaq
  • Market Cap
  • LGND 2.0B
  • ZGN 2.0B
  • IPO Year
  • LGND 1992
  • ZGN N/A
  • Fundamental
  • Price
  • LGND $102.19
  • ZGN $8.60
  • Analyst Decision
  • LGND Strong Buy
  • ZGN Buy
  • Analyst Count
  • LGND 8
  • ZGN 2
  • Target Price
  • LGND $144.71
  • ZGN $8.05
  • AVG Volume (30 Days)
  • LGND 118.3K
  • ZGN 973.0K
  • Earning Date
  • LGND 05-08-2025
  • ZGN 03-27-2025
  • Dividend Yield
  • LGND N/A
  • ZGN 1.58%
  • EPS Growth
  • LGND N/A
  • ZGN N/A
  • EPS
  • LGND N/A
  • ZGN 0.31
  • Revenue
  • LGND $181,488,000.00
  • ZGN $2,015,371,157.00
  • Revenue This Year
  • LGND $17.68
  • ZGN $0.79
  • Revenue Next Year
  • LGND $18.69
  • ZGN $4.69
  • P/E Ratio
  • LGND N/A
  • ZGN $27.69
  • Revenue Growth
  • LGND 53.40
  • ZGN 2.21
  • 52 Week Low
  • LGND $77.43
  • ZGN $6.05
  • 52 Week High
  • LGND $129.90
  • ZGN $12.77
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • ZGN 61.94
  • Support Level
  • LGND $98.90
  • ZGN $8.37
  • Resistance Level
  • LGND $103.17
  • ZGN $8.70
  • Average True Range (ATR)
  • LGND 3.05
  • ZGN 0.23
  • MACD
  • LGND -0.27
  • ZGN -0.03
  • Stochastic Oscillator
  • LGND 31.94
  • ZGN 65.29

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

Share on Social Networks: